- Rating
- 2
- Confidence
- 3
- Informativeness
- 2
- Presentation
- 2
- Soundness
- 1
Read review
Paper summary
This paper proposes ForesightMol, a chemistry-guided retrieval-augmented framework for structure-based drug design that integrates reference intervention, chemically constrained molecular growth, and multi-objective candidate selection. Experiments on 100 CrossDocked2020 test pockets demonstrate improved molecular quality and scaffold diversity over Rag2Mol-G.
Critical strengths
1.Meaningful problem formulation.
The paper identifies an important limitation of retrieval-augmented molecular generation: reference compatibility does not necessarily imply favorable downstream growth. Evaluating references through their induced generation trajectories provides a more outcome-oriented alternative to conventional similarity-based retrieval.
2.Coordinated generation and selection.
ForesightMol integrates rollout-verified reference intervention, chemical feasibility constraints, and multi-objective candidate selection into a coherent framework. The ablation studies provide evidence that these components contribute differently to molecular quality and structural diversity.
3.Improved candidate quality and diversity.
Experiments on CrossDocked2020 demonstrate that ForesightMol improves molecular quality and scaffold diversity over Rag2Mol-G with docking-based selection. Crossed comparisons further support the contributions of both generation and selection.
Critical weaknesses
- Limited methodological novelty beyond the integration of existing techniques.
Although ForesightMol presents a coherent framework, its main components rely on established techniques, including LLM-based heuristic assessment, autoregressive molecular generation, short-horizon rollout evaluation, valence filtering, and multi-objective candidate selection. The theoretical analysis establishes the limitations of similarity-based utility prediction, but it does not demonstrate that the proposed LLM-guided intervention mechanism is uniquely necessary or superior to simpler alternatives. The authors should better isolate the methodological novelty of the framework and clarify whether the improvements arise from the proposed coordination strategy or from combining existing techniques.
- Lack of Clarity and Inconsistencies in the Methodology
Several methodological descriptions and notations are ambiguous or incomplete, hindering understanding and reproducibility. First, in Section 3.1 (page 4), the authors define that “, where and denote atom coordinates and features, including element and residue types”. It is unclear whether this is an atom-level or residue-level representation. The former implies atomic coordinates and features, whereas the latter implies residue features and representative coordinates, such as those of Cα atoms. The authors should clarify the representation. Second, in Equation (3), in and the function are undefined. The meaning of the backslash symbol “\” in Equation (5) is also unclear. Third, the definition of “” is inconsistent: page 4, line 193, introduces “Given a references , …”, whereas page 5, line 222, states “For each challenger , …”. The authors should clarify its meaning and use the notation consistently. Fourth, on page 5, line 229, the source, role, and significance of the “random input ξ” are not explained. Fifth, Equation (8) separates three inequality conditions with commas, leaving it unclear whether the feasible set is defined by their intersection or union. The authors should use ∩ or ∪, as appropriate, to clarify their logical relationship. Sixth, the first function in Equation (10) is undefined, and in Equation (12) is insufficiently explained. Moreover, Equation (12) uses with , whereas page 6, line 270, defines as the set of existing atoms connected to the new atom. If denotes atom itself, the notation should be clarified, as would be more appropriate. Finally, page 6, line 285, mentions both “Vina Score” and “Vina Dock” evaluations. Appendix C (page 17, line 887) states that “Vina Score evaluates the generated pose, whereas Vina Dock evaluates the best energy…”. However, Vina Score is typically a numerical energy or affinity estimate in kcal/mol, rather than a pose itself. The authors should clarify the definitions, evaluation procedures, and differences between these metrics, particularly regarding their treatment of generated poses and binding energy.
- Limited generalization evaluation.
The experiments are conducted on only 100 CrossDocked2020 test pockets, leaving it unclear whether the observed improvements generalize to substantially different protein targets and retrieval distributions. Evaluation on more diverse targets and under different retrieval settings would strengthen the evidence for the framework's generalizability.
- Inconsistent Tense Usage.
On page 2, line 64, the authors write “We observed that reference value…”, using the past tense while the surrounding text consistently uses the present tense. The authors should check and ensure consistent tense usage throughout this passage.
Questions for authors
- Methodological Novelty.
Can the authors clarify the core methodological novelty of ForesightMol and provide evidence that the LLM-guided intervention mechanism outperforms simpler heuristic or learned alternatives?
- Methodological Clarity.
Can the authors clarify the ambiguous notations and definitions in Equations (3), (5), (8), (10), and (12), the protein pocket representation, the role of random input , and the distinction between Vina Score and Vina Dock?
- Generalization and Practical Utility.
Can the authors evaluate ForesightMol on more diverse protein targets and retrieval settings, and provide further evidence of its practical utility, particularly given the deterioration in redocking scores and the lack of experimental validation?
7 comments
Response Part II
W2&Q2. Clarification of ambiguous notation and definitions in Section 3, including the protein pocket representation, reference notation, random input , acceptance conditions, and Vina Score and Vina Dock evaluation procedures.
Thank you for your careful reading and valuable comments. We address each point below.
-
Unclear representation granularity in Section 3.1.
represents pocket heavy atoms. For each heavy atom , gives its coordinates, and denotes its scalar feature vector, encoding its element type, the amino-acid type of its parent residue, and its backbone/side-chain status.
-
Undefined notation in Equation (3).
In Equation (3), denotes the combined encoding and reference-interaction mapping, comprising the encoders and cross-context interaction module, with learnable parameters . It maps the current state and reference to the hidden representation . The superscripts and indicate its scalar and vector feature components, respectively.
-
Unclear backslash notation in Equation (5).
In Equation (5), denotes set difference. Thus, is the retrieved reference set excluding the current default reference .
-
Inconsistent use of reference notation .
Throughout, denotes a retrieved reference molecule. Equation (3) considers any , while “challenger” denotes its intervention role when selected by the agent from .
-
Unclear source and role of random input .
Here, denotes the randomness in sampling atom and bond types from the generator’s predicted distributions. This randomness supports diverse molecular exploration but can affect consistency across rollouts. We therefore use the same random seed for paired default-reference and challenger rollouts to control sampling variability when evaluating the effect of reference choice.
-
Unclear logical relationship among the conditions in Equation (8).
The three conditions in Equation (8) must hold simultaneously: sufficient rollout utility gain, risk increase within tolerance, and agent confidence meeting the threshold. We have connected the corresponding sets with to make this conjunction explicit.
-
Undefined and insufficiently explained notation in Equations (10) and (12).
In Equation (10), denotes the generator’s baseline action distribution over , conditioned on the current state and reference , before Agent-based reweighting.
In Equation (12), denotes the current partial ligand, and is the sum of the bond orders already incident to atom . The proposed bond adds to this sum. We intend to contain the indices of existing atoms connected to the new atom, while denotes the element type of atom . Thus, is the appropriate indexing relation, and gives the corresponding valence upper bound. We have explicitly defined these quantities and replace “existing atoms” with “indices of existing atoms” in the definition of .
-
Unclear definitions and evaluation procedures for Vina Score and Vina Dock.
Both metrics report a numerical binding-affinity estimate in kcal/mol using AutoDock Vina [1,2]. Vina Score evaluates the generated pose using
--score_only, without changing its position or conformation. Vina Dock performs redocking, allowing changes in ligand position, orientation, and rotatable bonds, then reports the lowest score among poses returned under the specified search settings. Both use the same scoring function, and lower values indicate more favorable predicted binding.
We have incorporated these clarifications into the revised manuscript to improve the consistency of the notation and the clarity of the methodological definitions.
[1] AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem. 2010.
[2] AutoDock Vina 1.2.0: New docking methods, expanded force field, and Python bindings. J Chem Inf Model. 2021.
Response Part III
W3&Q3. Further evaluation of ForesightMol on protein targets that differ substantially from those in CrossDocked2020 is needed to establish how well the framework generalizes.
Thank you for the helpful suggestion. Although CrossDocked2020 is widely used to benchmark structure-based drug design methods, generalization to targets outside the training distribution is important for real-world drug discovery. We used MMseqs2 [1] to compare protein targets from the Binding MOAD dataset [2], following the test split provided by DiffSBDD [3], against those from CrossDocked2020 to identify targets with low sequence similarity. We excluded entries with overlapping receptor PDB IDs or sequence matches with at least 30% identity over at least 80% of the shorter chain. After deduplicating entries by the sequences of their primary ligand-contacting chains, we retained thirty targets. We then compared the methods in a zero-shot setting, using their CrossDocked2020-trained checkpoints on the selected Binding MOAD targets without fine-tuning.
| Method | Mean QED ↑ | Best QED ↑ | SA ↓ | Lipinski ↑ | Mol. div. ↑ | Scaf. div. ↑ | Vina Score ↓ | Vina Dock ↓ |
|---|---|---|---|---|---|---|---|---|
| Pocket2Mol | 0.650 | 0.880 | 3.082 | 0.989 | 0.827 | 0.521 | −3.1379 | −6.7003 |
| MolCRAFT | 0.647 | 0.876 | 2.506 | 0.922 | 0.879 | 0.664 | −3.9248 | −6.3149 |
| TargetDiff | 0.595 | 0.870 | 3.411 | 0.923 | 0.904 | 0.744 | −2.2568 | −6.1686 |
| Rag2Mol-G | 0.663 | 0.859 | 3.203 | 0.946 | 0.797 | 0.666 | −4.1774 | −7.3941 |
| ForesightMol | 0.690 | 0.891 | 2.307 | 0.947 | 0.805 | 0.709 | −4.2553 | −7.6031 |
As shown in the table above, ForesightMol achieves the best results on five of eight metrics among the evaluated methods, including mean and best QED, SA, Vina Score, and Vina Dock. Relative to Rag2Mol-G, ForesightMol improves molecular quality and scaffold diversity while also achieving a more favorable redocking score. Together, these results provide empirical evidence that the benefits of ForesightMol extend to targets with low sequence similarity to those in CrossDocked2020 under zero-shot evaluation.
[1] MMseqs2 enables sensitive protein sequence searching for the analysis of massive data sets. Nat Biotechnol. 2017.
[2] Binding MOAD (mother of all databases). Proteins. 2005.
[3] Structure-based drug design with equivariant diffusion models. Nat Comput Sci. 2024.
[4] Pocket2Mol: Efficient molecular sampling based on 3D protein pockets. ICML. 2022.
[5] MolCRAFT: Structure-based drug design in continuous parameter space. ICML. 2024.
[6] 3D equivariant diffusion for target-aware molecule generation and affinity prediction. ICLR. 2023.
[7] Rag2Mol: Structure-based drug design based on retrieval augmented generation. Brief Bioinform. 2025.
W4. Inconsistent tense usage on page 2.
Thank you for pointing this out. We have changed “We observed” to “We observe” to match the surrounding text. We have also proofread the entire manuscript to improve clarity and consistency.
We sincerely thank you for your thoughtful comments and careful review, which have helped strengthen our manuscript. If our responses and additional evidence have satisfactorily addressed your concerns, we respectfully ask that you consider increasing your score. We would be pleased to provide any further clarification and greatly appreciate the time and effort you have devoted to evaluating our work.
Response Part I
Thank you for the helpful suggestions. We clarify the core methodological novelty of ForesightMol below and present additional controlled experiments to evaluate the benefits of LLM-guided intervention over simpler or heuristic alternatives.
Existing LLM-assisted molecular design frameworks have successfully supported task planning and tool orchestration [1,2], yet how to translate pretrained chemical knowledge into actionable guidance during molecular generation remains underexplored [3]. ForesightMol addresses this gap by connecting LLM chemical knowledge with the evolving generation state through context engineering and verifying proposed interventions through short-horizon rollouts. This design enables chemical expertise to inform molecular growth, while evidence-grounded explanations support subsequent candidate prioritization. Specifically, our technical novelty comprises two aspects.
Thoroughly structured context engineering activates chemical knowledge of LLM. By investigating chemical knowledge, we structure the current generation state, reference descriptors, and growth diagnostics into chemical contexts, enabling the LLM to apply pretrained knowledge to reference prioritization and translate verified assessments into additional biases at the prediction heads for molecular growth.
Set-level portfolio optimization with evidence-grounded explanations. We formulate fixed-budget portfolio selection as a joint optimization of molecular quality, predicted binding compatibility, structural diversity, and pocket coverage. The LLM integrates input-design and generation decisions with selection evidence to provide a traceable rationale for each included molecule, helping researchers identify promising candidates for downstream evaluation.
Evidence supporting LLM-guided intervention. To isolate the contribution of LLM guidance and compare it with simpler alternatives, we evaluate six controlled configurations under the same experimental settings. The similarity-based selector ranks references by structural similarity to the current molecule, whereas the heuristic-based selector applies scoring rules that reward chemical compatibility and favorable pocket contacts while penalizing steric clashes and size mismatch. We evaluate the full generated candidate pools before portfolio selection to assess the effects of the generation-stage mechanisms.
As shown in the table above, the agent-only variant (C) improves mean QED and both Vina metrics over similarity-based (A) and heuristic-based (D) selection, even without rollout verification or prediction-head guidance. Rollout alone (B) yields limited gains, whereas combining it with LLM assessment (E) improves mean QED and diversity over (C). The full method (F) performs best across all reported metrics.
[1] Liddia: Language-based intelligent drug discovery agent. EMNLP. 2025.
[2] Rethinking chemical research in the age of large language models. Nat Comput Sci. 2025.
[3] From generalist to specialist: A survey of large language models for chemistry. COLING. 2025.